Alcorn, K. (2005) Second Company Halts CCR5 Inhibitor Study in Another Blow to New Drug Class: NAM Aids Map.
http://www.aidsmap.com/Second-company-halts-CCR5-inhibitorstudy-in-another-blow-to-new-drug-class/page/1422234/

has been cited by the following article: